skip to Main Content

Intrinsa Testoserone Patch Denied By SMC

The Scottish Medicines Consortium have today issued guidance denying the use of the testosterone patch manufactured by Intrinsa to NHS patients in Scotland saying “Testosterone transdermal patch (Intrinsa) for the treatment of hypoactive sexual desire disorder (HSDD) in surgically induced menopausal women. The manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.” You can read the complete statement of Final Advice on their website at: scottishmedicines.org.uk/smc/5512.html 

Advertisements

Linda Parkinson-Hardman

Transformational coach and founder of the Hysterectomy Association. Professionally I'm an information scientist who specialises in the adoption and engagement of digital technologies. I am a writer and author of nine books to date, and I've edited a further seven; phew what a lot for a Thursday afternoon :-)

This Post Has 2 Comments
  1. Intrinsa was only refused by the SMC because it couldn’t demonstrate a good enough financial reason to be placed on their approved medicines to be prescribed through the NHS. I believe that the research evidence has suggested that it is highly effective. Linda

  2. I have not long ago been prescribed Intrinsa, has anyone else? I have not used it yet, but I am suffering from a failing libido, and was advised this will help – please help

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top
%d bloggers like this: